focus -WSS

focus

author：hotspot 2025-09-30 00:39:02 - browse：6

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： How to fix cancer clinical trials' diversity problem

WSS

Why are elite athletes different? Take a look at their microbes

Amazon on where the company's health care bets are headed next

What American doctors can learn from their Israeli counterparts

NIH nominee Bertagnolli will get October confirmation hearing

Why Novartis is changing the name of its research labs

What American doctors can learn from their Israeli counterparts

focus

focus

entertainment

Hollywood unions extend contract negotiations for actors

What drug price negotiations mean for Medicare Part D

How to save PrEP access — and even expand it

Disclosing genetic information: not as worrisome as once feared

In age of alternative facts, a scholarly course on calling out crap

CDC concerned about possible undetected monkeypox spread in U.K.

Medicare proposal to cover medical devices draws a mixed reaction

3 hurdles to bringing medical devices to the U.S. market

Wildfire smoke exposes gaps in outdoor worker protections

Why we need to separate burnout from moral injury in health care

knowledge

Donald Trump's relentless attacks on special counsel Jack Smith

Why Novartis is changing the name of its research labs

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

STAT's guide to the next generation of CAR

The strategy behind pharma's lawsuits over drug pricing reform

Why are elite athletes different? Take a look at their microbes

Wikipedia

hotspot

explore

Wikipedia